Cargando…

443. Do people living with HIV lose weight on GLP-1 agonist therapy?

BACKGROUND: Anti-retroviral therapy (ART) has been associated with significant weight gain and metabolic derangements in persons with HIV (PWH), and many PWH on ART experience comorbid obesity. GLP-1 receptor agonists (GLP-1RA) are used to treat type-2 diabetes and obesity in people without HIV infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tauhid, Lamiya, Fondong, Mima, Lovett, Aish, Kissinger, Patricia J, Bennani, Yussef, Clement, Meredith E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752354/ http://dx.doi.org/10.1093/ofid/ofac492.518

Ejemplares similares

443 Team Science
por: Miah, Sayem, et al.
Publicado: (2023)

Tracheostomy in the ICU: an analysis of 443 procedures
por: Marbán, A, et al.
Publicado: (2009)

Do patients lose weight after total hip arthroplasty?()()
por: Schwartsmann, Carlos Roberto, et al.
Publicado: (2014)

Do patients lose weight after total knee replacement?()
por: Schwartsmann, Carlos Roberto, et al.
Publicado: (2017)

SUN-443 Surgical Management of Cystic Prolactinomas
por: Nevzati, Edin, et al.
Publicado: (2019)

To Lose Weight or Not to Lose Weight, That Is the Big Question—in Obesity-Related Heart Failure
por: Peterson, Linda R.
Publicado: (2015)

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
por: Mosterd, Charlotte M., et al.
Publicado: (2020)

GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
por: Ryan, Donna, et al.
Publicado: (2015)

443 Non-Typhoidal Salmonella Infections in Cancer Patients
por: Mori, Nobuyoshi, et al.
Publicado: (2014)

Neuromedin U-deficient rats do not lose body weight or food intake
por: Yokogi, Kyoka, et al.
Publicado: (2022)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

1982. GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV
por: Nguyen, Quynh P, et al.
Publicado: (2023)

Losing weight for a better health: Role for the gut microbiota
por: Dao, Maria Carlota, et al.
Publicado: (2016)

443. West Nile Virus in Humans in Greece, 2010–2017
por: Pervanidou, Danai, et al.
Publicado: (2018)

MON-443 Periostin Concentrations in Childhood-Onset Craniopharyngioma Patients
por: Heinks, Kerstin, et al.
Publicado: (2019)

THU443 Acute Iridocyclitis Associated With Intravenous Zoledronic Acid
por: Ankireddypalli, Anvitha Reddy, et al.
Publicado: (2023)

The Cardiovascular Effects of GLP-1 Receptor Agonists
por: Okerson, Theodore, et al.
Publicado: (2012)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Clinical Trial Highlights – GLP-1 agonists
por: McFarthing, Kevin, et al.
Publicado: (2020)

Fat People Lose Weight Communally
Publicado: (1954)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

M4.4.3 Annual EuroNNAc workshop 2012
por: Assmann, R
Publicado: (2012)

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

Is Losing Weight Worth Losing Your Kidney: Keto Diet Resulting in Renal Failure
por: Ayele, Girma M, et al.
Publicado: (2023)

Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
por: Wang, Qinghua, et al.
Publicado: (2010)

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
por: Knerr, Patrick J., et al.
Publicado: (2022)

Basal Insulin Use With GLP-1 Receptor Agonists
por: Anderson, Sarah L., et al.
Publicado: (2016)

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
por: Zhao, Xin, et al.
Publicado: (2021)

Development of an mHealth App to Support the Prevention of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Engaged in Pre-exposure Prophylaxis Care in New Orleans, Louisiana: Qualitative User-Centered Design Study
por: Clement, Meredith Edwards, et al.
Publicado: (2023)

The Gastric Sleeve: Losing Weight as Fast as Micronutrients?
por: Aarts, Edo O., et al.
Publicado: (2010)

The ambivalence of losing weight after bariatric surgery
por: Warholm, Christine, et al.
Publicado: (2014)

SAT443 Prevalence Of Immune Checkpoint Inhibitor-related Endocrinopathies In Patients With Cancers
por: Pittampalli, Shanti, et al.
Publicado: (2023)

Lose Pain, Lose Weight, and Lose Both: A Cohort Study of Patients with Chronic Pain and Obesity Using a National Quality Registry
por: Dong, Huan-Ji, et al.
Publicado: (2021)

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis
por: Piccoli, Giovana Fagundes, et al.
Publicado: (2021)

Do Black Women’s Religious Beliefs About Body Image Influence Their Confidence in Their Ability to Lose Weight?
por: Bauer, Alexandria G., et al.
Publicado: (2017)

Why Do Most Restrained Eaters Fail in Losing Weight?: Evidence from an fMRI Study
por: Su, Yanhua, et al.
Publicado: (2019)

Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
por: Trapp, Stefan, et al.
Publicado: (2021)

The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile
por: Larsen, Anna Thorsø, et al.
Publicado: (2021)

Who will lose weight? A reexamination of predictors of weight loss in women
por: Teixeira, Pedro J, et al.
Publicado: (2004)

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
por: Helmstädter, Johanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kio9n1tecoej1ut9819mkvf4qb